症例報告: 三重原発がん (肺,胃,腸) の治療に成功し,シンチリマブを化学療法と標的療法と併用した.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。この症例報告は 肺腺癌,胃シール・リング・セル癌,直腸癌を含む シンクロン複数の原発がんの 珍しい事例を詳細に説明しています. 免疫療法 (シンチリマブ) と化学療法による統合アプローチは,有望な疾患制御を示した.
科学分野
- 腫瘍学
- 医療 症例 の 報告
背景
- シンクロナスの多発性原発がんは稀であり,複雑な治療課題を伴う.
- 異なる同時発症の悪性腫瘍を患っている患者に有効な管理戦略が必要である.
研究 の 目的
- 肺,胃,直腸の 複数の原発がんを報告する
- この文脈で統合免疫療法と化学療法の有効性を評価する.
主な方法
- シンクロン肺腺がん,胃シールリング細胞がん,直腸がんを患った64歳の男性患者が治療を受けました.
- システム療法には,シンチリマブ (免疫療法),オキシリプラチン,ケープシタビン (化学療法),およびフルモネルチニブ (標的療法) が含まれていた.
主要な成果
- 治療の6サイクル後に肺損傷の有意な減少が観察されました.
- 胃と直腸の腫瘍は安定しており,病気のコントロールを示しています.
- 患者は持続的な病気制御を達成し,維持治療に重度の副作用はなかった.
結論
- 統合免疫療法と化学療法のアプローチは,同時多発性原発性悪性腫瘍の管理の可能性を示しています.
- 個別化されたバイオマーカー主導の治療戦略は 結果の最適化に不可欠です
- これらの複雑な症例の最適の治療組み合わせを決定するために,さらなる研究が必要である.
関連する概念動画
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.